miR-20a targets BNIP2 and contributes chemotherapeutic resistance in colorectal adenocarcinoma SW480 and SW620 cell lines.
about
MicroRNAs in colorectal carcinoma--from pathogenesis to therapyAn update on microRNAs as colorectal cancer biomarkers: where are we and what's next?The Effects of Antisense miRNA-20a Alone or in Combination with Imatinib on K562 Cell ProliferationColorectal Cancer: From the Genetic Model to Posttranscriptional Regulation by Noncoding RNAs.Epigenetic Alterations in Colorectal Cancer: Emerging Biomarkers.High expression of microRNA-625-3p is associated with poor response to first-line oxaliplatin based treatment of metastatic colorectal cancer.Oncogenic Role of miR-15a-3p in 13q Amplicon-Driven Colorectal Adenoma-to-Carcinoma ProgressionThe potential of plasma miRNAs for diagnosis and risk estimation of colorectal cancer.The role of microRNAs in colorectal cancer.DNMT1 mediates chemosensitivity by reducing methylation of miRNA-20a promoter in glioma cells.MicroRNA manipulation in colorectal cancer cells: from laboratory to clinical application.miR-17-92a-1 cluster host gene (MIR17HG) evaluation and response to neoadjuvant chemoradiotherapy in rectal cancer.Involvement of miR-20a in promoting gastric cancer progression by targeting early growth response 2 (EGR2)Post-transcriptional controls by ribonucleoprotein complexes in the acquisition of drug resistance.Serum microRNA expression levels can predict lymph node metastasis in patients with early-stage cervical squamous cell carcinomaMicroRNA-93-5p increases multidrug resistance in human colorectal carcinoma cells by downregulating cyclin dependent kinase inhibitor 1A gene expression.MicroRNAs in the etiology of colorectal cancer: pathways and clinical implications.MicroRNAs in gastrointestinal cancer: prognostic significance and potential role in chemoresistance.MicroRNAs as potential drug targets for therapeutic intervention in colorectal cancer.MicroRNAs predict and modulate responses to chemotherapy in colorectal cancer.miR-205 mediates the inhibition of cervical cancer cell proliferation using olmesartan.Circulating microRNA-451 as a predictor of resistance to neoadjuvant chemotherapy in breast cancer.Involvement of Non-coding RNAs in Chemo- and Radioresistance of Colorectal Cancer.miR-20a enhances cisplatin resistance of human gastric cancer cell line by targeting NFKBIB.microRNAs and Colorectal Cancer.Suppression of CX43 expression by miR-20a in the progression of human prostate cancer.Genomic characterization of liver metastases from colorectal cancer patients.miR-506 enhances the sensitivity of human colorectal cancer cells to oxaliplatin by suppressing MDR1/P-gp expression.MicroRNAs and their role for T stage determination and lymph node metastasis in early colon carcinoma.A miR-20a/MAPK1/c-Myc regulatory feedback loop regulates breast carcinogenesis and chemoresistance.Downregulation of leucine-rich repeats and immunoglobulin-like domains 1 by microRNA-20a modulates gastric cancer multidrug resistance.Elevated expression of CCAT2 is associated with poor prognosis in esophageal squamous cell carcinoma.
P2860
Q26766510-F443DA4F-E956-437A-B5B7-0219A959F132Q27024427-D58FA5D4-D2F7-4649-9A83-94566A8A324DQ32179310-C02FAEA1-A826-4940-9C7F-38AD4EFB358BQ33720978-56D0FDD1-BB9E-485C-B7FA-0D1AC4A52452Q34487177-919BCE0A-3E96-46D1-B3DF-6157DD5ADC40Q34626744-2D90B1B6-E13D-4F87-8E68-D21C40940696Q35684205-832E7771-0A79-4569-B7EE-33B1A4CC7F32Q35919291-1C08BD56-9AAF-4CB0-8F16-C342CB04E736Q36096641-A9FBBDBA-5B18-45AF-B796-E6BFB543108FQ36294437-44669C1D-A531-4E5C-8892-CDE5F69AB809Q36517482-7E5E0089-4176-4CEC-94CD-1305D313FFEFQ36900550-17DFFE48-7E9D-418B-8D04-7D88EAECC8C6Q37139148-56DF30EF-E5C1-4486-A8D4-D223210FCC18Q37139289-9694F8E5-7217-4D3F-98FA-7DEAD37F1CA1Q37196131-51D62A95-F3BD-4733-9442-7A59082F2981Q37700939-19D7752F-B2A1-455F-BDF1-F9D3D26DA99EQ37731180-6117E606-9FAD-421F-8E79-B83EE0F7E48EQ38202662-FFA9F7FF-736E-41DE-95BD-736E89C7C6FFQ38550157-0BA1C712-90F8-4D9C-8B16-72F4F5179975Q38552402-DBBC4FF4-667F-40DE-9453-16B2EF41CF4BQ38711866-60A96571-E128-4CA6-82B8-9A4D44236D56Q38779495-EBAC3E54-0CC6-493E-B026-4133C711C1C4Q38826542-BCCB7CBC-0EC7-4D6A-92A2-919FE5B626E1Q38842690-12D977BA-2345-41BA-AEB6-57DE0014ECFDQ38932823-DE2A88A1-4C8C-497F-BC54-7501C51B9EE5Q39316336-B05A4AEC-6F43-40B8-AD52-99E3987FBC5EQ42317553-14296E16-6184-4599-ACD6-D7B4A8179C68Q48219033-8ED6BE85-FE25-4536-9374-F7236F83156CQ48310742-9D236ACE-17B2-4FF7-A8B7-0EEB488A8EE3Q48604832-363CB7FA-29A9-4B3D-832D-BBDC8F90332AQ49945042-0CE1D365-4C44-4F7E-96A1-C3C3FEC9A2CFQ53526654-FBF9C639-8D04-4426-9408-708E6D10368F
P2860
miR-20a targets BNIP2 and contributes chemotherapeutic resistance in colorectal adenocarcinoma SW480 and SW620 cell lines.
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
2011年论文
@zh
2011年论文
@zh-cn
name
miR-20a targets BNIP2 and cont ...... ma SW480 and SW620 cell lines.
@en
miR-20a targets BNIP2 and cont ...... ma SW480 and SW620 cell lines.
@nl
type
label
miR-20a targets BNIP2 and cont ...... ma SW480 and SW620 cell lines.
@en
miR-20a targets BNIP2 and cont ...... ma SW480 and SW620 cell lines.
@nl
prefLabel
miR-20a targets BNIP2 and cont ...... ma SW480 and SW620 cell lines.
@en
miR-20a targets BNIP2 and cont ...... ma SW480 and SW620 cell lines.
@nl
P2093
P2860
P356
P1476
miR-20a targets BNIP2 and cont ...... ma SW480 and SW620 cell lines.
@en
P2093
P2860
P304
P356
10.1093/ABBS/GMQ125
P577
2011-01-17T00:00:00Z